Search

Your search keyword '"Pirfenidone -- Forecasts and trends -- Reports"' showing total 9 results
Start Over Descriptor "Pirfenidone -- Forecasts and trends -- Reports"
9 results on '"Pirfenidone -- Forecasts and trends -- Reports"'

1. Global Idiopathic Pulmonary Fibrosis Treatment Market to 2025 by Drug Class, End User, Value Chain Analysis, Price Analysis, Competitive Landscape - ResearchAndMarkets.com

Subjects
Pulmonary fibrosis -- Forecasts and trends -- Reports, Respiratory system agents -- Forecasts and trends -- Reports, Nintedanib -- Forecasts and trends -- Reports, Pirfenidone -- Forecasts and trends -- Reports, Market trend/market analysis, Business, Business, international
Abstract

DUBLIN -- The 'Idiopathic Pulmonary Fibrosis Treatment Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2020-2025' report has been added to ResearchAndMarkets.com's offering. The global idiopathic pulmonary fibrosis [...]

Published
2020

2. Esbriet (pirfenidone) - Drug Insight and Market Forecast - 2030

Subjects
Pirfenidone -- Forecasts and trends -- Reports, Market trend/market analysis, Banking, finance and accounting industries, Business, Esbriet (Medication) -- Reports
Abstract

New York, Aug 26, 2020 (GLOBE NEWSWIRE via COMTEX) -- Reportlinker.com announces the release of the report 'Esbriet (pirfenidone) - Drug Insight and Market Forecast - 2030' - https://www.reportlinker.com/p05865968/?utm_source=GNW A [...]

Published
2020

3. Diffuse cutaneous systemic sclerosis (dcSSc) Market Size, Epidemiology, Leading Companies, Drugs and Competitive Analysis by DelveInsight

Subjects
Business research -- Reports -- Forecasts and trends, Brodalumab -- Reports -- Forecasts and trends, Drugs -- Reports -- Forecasts and trends, Scleroderma (Disease) -- Reports -- Forecasts and trends, Nintedanib -- Forecasts and trends -- Reports, Epidemiology -- Reports -- Forecasts and trends, Belimumab -- Reports -- Forecasts and trends, Pirfenidone -- Forecasts and trends -- Reports, Market trend/market analysis, Business, Business, international
Abstract

M2 PRESSWIRE-July 31, 2020-: Diffuse cutaneous systemic sclerosis (dcSSc) Market Size, Epidemiology, Leading Companies, Drugs and Competitive Analysis by DelveInsight (C)1994-2020 M2 COMMUNICATIONS RDATE:30072020 (Albany, US) Delveinsight has launched a [...]

Published
2020

4. Progressive-Fibrosing Interstitial Lung Disease (PF-ILD) 2020-2028 - Market Insights, Epidemiology and Market Forecasts

Subjects
Medical research -- Reports -- Forecasts and trends, Nintedanib -- Forecasts and trends -- Reports, Epidemiology -- Reports -- Forecasts and trends, Lung diseases -- Forecasts and trends -- Reports, Pirfenidone -- Forecasts and trends -- Reports, Market trend/market analysis, Banking, finance and accounting industries
Abstract

(GlobeNewswire) - The 'Progressive-Fibrosing Interstitial Lung Disease (PF-ILD) - Market Insights, Epidemiology, and Market Forecast - 2028' drug pipelines has been added to ResearchAndMarkets.com's offering. The 'Progressive-Fibrosing Interstitial Lung Disease [...]

Published
2020

5. Progressive-Fibrosing Interstitial Lung Disease (PF-ILD) 2020-2028 - Market Insights, Epidemiology and Market Forecasts

Subjects
Medical research -- Reports -- Forecasts and trends, Nintedanib -- Forecasts and trends -- Reports, Epidemiology -- Reports -- Forecasts and trends, Lung diseases -- Forecasts and trends -- Reports, Pirfenidone -- Forecasts and trends -- Reports, Market trend/market analysis, Business, international, Law
Abstract

(GlobeNewswire) - The 'Progressive-Fibrosing Interstitial Lung Disease (PF-ILD) - Market Insights, Epidemiology, and Market Forecast - 2028' drug pipelines has been added to ResearchAndMarkets.com's offering. The 'Progressive-Fibrosing Interstitial Lung Disease [...]

Published
2020

6. Global Market Outlook and Epidemiology for Progressive-Fibrosing Interstitial Lung Disease (PF-ILD) 2020-2028

Subjects
Medical research -- Reports -- Forecasts and trends, Nintedanib -- Forecasts and trends -- Reports, Epidemiology -- Reports -- Forecasts and trends, Lung diseases -- Forecasts and trends -- Reports, Pirfenidone -- Forecasts and trends -- Reports, Market trend/market analysis, Business, Business, international
Abstract

M2 PRESSWIRE-July 29, 2020-: Global Market Outlook and Epidemiology for Progressive-Fibrosing Interstitial Lung Disease (PF-ILD) 2020-2028 (C)1994-2020 M2 COMMUNICATIONS RDATE:29072020 The 'Progressive-Fibrosing Interstitial Lung Disease (PF-ILD) - Market Insights, Epidemiology, [...]

Published
2020

7. Global Market Outlook and Epidemiology for Progressive-Fibrosing Interstitial Lung Disease (PF-ILD) 2020-2028 - ResearchAndMarkets.com

Subjects
Medical research -- Reports -- Forecasts and trends, Nintedanib -- Forecasts and trends -- Reports, Epidemiology -- Reports -- Forecasts and trends, Lung diseases -- Forecasts and trends -- Reports, Pirfenidone -- Forecasts and trends -- Reports, Market trend/market analysis, Business, Business, international
Abstract

DUBLIN -- The 'Progressive-Fibrosing Interstitial Lung Disease (PF-ILD) - Market Insights, Epidemiology, and Market Forecast - 2028' drug pipelines has been added to ResearchAndMarkets.com's offering. The 'Progressive-Fibrosing Interstitial Lung Disease [...]

Published
2020

8. Progressive-Fibrosing Interstitial Lung Disease (PF-ILD) 2020-2028 - Market Insights, Epidemiology and Market Forecasts

Subjects
Medical research -- Reports -- Forecasts and trends, Nintedanib -- Forecasts and trends -- Reports, Epidemiology -- Reports -- Forecasts and trends, Lung diseases -- Forecasts and trends -- Reports, Pirfenidone -- Forecasts and trends -- Reports, Market trend/market analysis, Banking, finance and accounting industries, Business
Abstract

Dublin, July 29, Jul 29, 2020 (GLOBE NEWSWIRE via COMTEX) -- The 'Progressive-Fibrosing Interstitial Lung Disease (PF-ILD) - Market Insights, Epidemiology, and Market Forecast - 2028' drug pipelines has been [...]

Published
2020

9. Bronchiolitis Obliterans Syndrome Market Size, Share, Trend, Epidemiology & Market Forecast to 2030

Subjects
Business research -- Forecasts and trends -- Reports, Brand equity -- Forecasts and trends -- Reports, Ruxolitinib -- Forecasts and trends -- Reports, Epidemiology -- Forecasts and trends -- Reports, Pirfenidone -- Forecasts and trends -- Reports, Bronchiolitis -- Forecasts and trends -- Reports, Profits, Market trend/market analysis, Business, Business, international
Abstract

M2 PRESSWIRE-April 2, 2020-: Bronchiolitis Obliterans Syndrome Market Size, Share, Trend, Epidemiology & Market Forecast to 2030 (C)1994-2020 M2 COMMUNICATIONS RDATE:01042020 DelveInsight's 'Bronchiolitis Obliterans Syndrome Market Insights, Epidemiology, and Market [...]

Published
2020

Catalog

Books, media, physical & digital resources
See catalog results